Mechanical ventilation (MV) is a widely used treatment modality for the management of respiratory failure in intensive care units (ICU). An estimated 300,000 patients undergo MV annually in the U.S.
Researchers at Stanford have developed methods of using CRISPR/Cas9-mediated genome editing to treat patients with EGFR-mutant non-small-cell lung cancer (NSCLC). Approximately 85% of lung cancers are NSCLC.